08/27/2008
Medication Slows Nearsightedness In Children
Daily treatment with pirenzepine can slow the rate of progressive myopia in children, according to an article published on August 26, 2008 in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS). When someone is myopic, or nearsighted, he is able to focus on objects that are close to the eye but objects that are more distant appear blurry.
more info
|
08/26/2008
Bayer HealthCare And Regeneron Announce VEGF Trap-Eye Achieved Durable Improvement In Vision Over 52 Weeks In A Phase 2
Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that patients with wet age-related macular degeneration (AMD) receiving VEGF Trap-Eye in a Phase 2 extension study on a PRN (as needed) dosing schedule continued to show highly significant improvements at 52 weeks in the primary and key secondary endpoints of retinal thickness (an anatomic measure of treatment effect) and vision gain.
more info
|
08/26/2008
The Alcon Research Institute Recognizes Seven Top Researchers In Ophthalmology With Unrestricted Grants
Now in its 28th year, the Alcon Research Institute (ARI) recognized seven outstanding researchers who have dedicated their lives to enhancing the understanding of vision and eye health. These seven doctors, who were nominated by previous winners and selected by ARI's independent Scientific Selection Committee, will receive $100,000 in unrestricted grant money from the ARI to continue pursuing their research into the underlying causes of eye disease.
more info
|
08/24/2008
VEGF Trap-Eye Achieved Durable Improvement In Vision Over 52 Weeks In A Phase 2 Study In Patients With AMD
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare AG announced that patients with wet age-related macular degeneration (AMD) receiving VEGF Trap-Eye in a Phase 2 extension study on a PRN (as needed) dosing schedule continued to show highly significant improvements at 52 weeks in the primary and key secondary endpoints of retinal thickness (an anatomic measure of treatment effect) and vision gain.
more info
|
08/22/2008
Using Plastic Coatings To Help Medical Implants Connect With Neurons
Plastic coatings could someday help neural implants treat conditions as diverse as Parkinson's disease and macular degeneration. The coatings encourage neurons in the body to grow and connect with the electrodes that provide treatment. Jessica O. Winter, assistant professor of chemical and biomolecular engineering at Ohio State University described the research at the American Chemical Society meeting in Philadelphia.
more info
|
